# Generate Biomedicines, Inc. (GENB) - Q2 2026 earnings

Reported August 6, 2026.

| | Reported | Consensus estimate |
| --- | --- | --- |
| Revenue | $6.3M | $5.3M |
| EPS | $-0.52 | $-0.51 |

Earnings filing reader: [8-K 0001193125-26-336462](https://www.opencapital.sh/filings/0001193125-26-336462)
Agent-readable filing: [Markdown](https://www.opencapital.sh/filings/0001193125-26-336462.md)
Original filing: [SEC.gov filing index](https://www.sec.gov/Archives/edgar/data/2100782/000119312526336462/0001193125-26-336462-index.htm)
Periodic report: 10-Q - https://www.sec.gov/Archives/edgar/data/2100782/000119312526336437/0001193125-26-336437-index.htm
Canonical page (please cite this URL): https://www.opencapital.sh/stocks/genb/earnings/q2-2026